Navigation Links
Contraceptive Patch Carries Risk of Blood clots

The U.S. Food and Drug Administration on Wednesday reported having updated the warning label on the Ortho Evra birth-control patch, cautioning users about the higher risk of blood clots from it.//

The drug manufacturer Johnson and Johnson’s commissioned study revealed that drug users faced two times the risk of clots in the legs and lungs compared to women taking traditional birth-control pills.

Another study commissioned by Johnson and Johnson, however, found no difference in risk between the patch and the pill. The FDA said, "Even though the results of the two studies are conflicting, the results of the second epidemiology study support FDA's concerns regarding the potential for Ortho Evra use to increase the risk of blood clots in some women."

Dr. Daniel Shames, the acting deputy director of FDA's Office of Drug Evaluation in the Center for Drug Evaluation and Research, said, "Blood clots occurring in the legs or lungs are serious and rare events that are a potential risk for all hormonal contraceptive therapies."

Shames said that risk factors for blood clots associated with contraceptives include smoking, inactivity, obesity, surgery and high doses.

The FDA has also required Johnson and Johnson to conduct a longer follow-up study of women using the patch to check for developments of heart attack, blood clots and stroke. Currently, the FDA believes the patch is safe for most women. Shames said, "Ortho Evra risk profile is acceptable for a highly effective contraceptive."

However the FDA’s concerns about the potential risk of blood clots in some women could not be ruled.

Earlier information that had been reported by Johnson and Johnson in a Feb. 16, 2006, press release was also included in the label change. This information was partly based, on an interim report from one of the two studies. The FDA said that the label change announced on Wednesday is based on the latest results from the two studies.

According to the label change women using the weekly patch which is the only birth-control patch approved by the FDA is taking in substantially more estrogen than women who take a daily birth-control pill. These pills typically contain 35 micrograms of estrogen. These higher levels of estrogen put some women at increased risk of blood clots.

Dr. Steven R. Goldstein, a professor of obstetrics and gynecology at New York University School of Medicine said, "When the patch came out, I enthusiastically used [it] in women who don't like to take pills. But I thought that there was too much estrogen in it, because four of the women lasted one or two months and complained of symptoms, which are usually attributed to excess estrogen."

He added, "My advice is that for a patient who had been on the patch for any period of time and is doing well, I don't see a need to take her off. With most of the estrogen-related blood clots, the risk is greatest in the first six months of use."


NL
'"/>




Related medicine news :

1. Contraceptives via Internet
2. FDA Approves Contraceptive Ring
3. Contraceptives decreases Libido
4. Contraceptives have dual effects
5. Drugs For Anthrax May Interfere With Oral Contraceptives
6. Contraceptive pill to reduce PMS
7. Smoking and Oral Contraceptives:
8. Contraceptive pills may lead to deformities in babies
9. Low-Dose Oral Contraceptives May Increase Risk For Heart Attack Or Stroke
10. Prevent Multiple Sclerosis From Oral Contraceptives
11. Usage Of Oral Contraceptives Need Not Be Feared By SLE Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... York, NY (PRWEB) , ... April 29, 2016 , ... New York City based oral ... . This surgery is a very effective way to treat obstructive sleep apnea. Dr. Jamali ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This surgery ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Products, Inc. in an upcoming episode, airing third quarter 2016 via Discovery Channel. ... cream into butter, Grassland Dairy Products, located in Greenwood, Wisconsin applies product research ...
(Date:4/29/2016)... ... April 29, 2016 , ... Nike Softball Camp at ... from July 24th – 27th for girls aged 10-18. All facets of the game ... the beautiful Clark V. Whited Complex, one of the finest softball facilities in the ...
(Date:4/29/2016)... ... 2016 , ... Coalition Duchenne, a Newport Beach, California based ... research, participated in the April 25 U.S. Food and Drug Administration advisory committee ... meeting at the Marriott Conference Center in Hyattsville, Maryland was attended by over ...
(Date:4/29/2016)... Viejo, CA (PRWEB) , ... April 29, 2016 , ... ... Pro X. Utilize Pixel Film Studios’ lower thirds to introduce people, characters, and locations ... styles that include boxes, lines, accents, textures and many more design components. Simply select ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... ISELIN, New Jersey , April 29, 2016 ... Omnichannel Software Suite for Life Sciences, Product Development ... and Global Life Science Customer Base . ... healthcare solutions provider, today announced the acquisition of ... is a global leader in adaptive sales enablement ...
(Date:4/28/2016)... 28, 2016   Click here for supplemental ... (NYSE: DPLO), the nation,s largest independent specialty pharmacy, ... agreement to acquire Valley Campus Pharmacy, Inc., doing ... leading specialty pharmacy that provides individualized patient care, ... . In 2015, TNH generated approximately $400 million ...
(Date:4/28/2016)... April 28, 2016 ... George Phillips und Stephen Schmidt ... ArisGlobal®, ein führender Anbieter cloudbasierter ... heute bekannt, dass neue Führungskräfte zum Team ... sind, die vielfältige Erfahrungen mitbringen.  Dies wird ...
Breaking Medicine Technology: